Parnes H - Search Results

1

Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics.

Conley BA, O'Hara S, Wu S, Melink TJ, Parnes H, Pardoe E, Egorin MJ, Van Echo DA. Conley BA, et al. Among authors: parnes h. Cancer Chemother Pharmacol. 1995;37(1-2):139-49. doi: 10.1007/BF00685641. Cancer Chemother Pharmacol. 1995. PMID: 7497583 Clinical Trial.

2

Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma.

Parnes HL, Abrams JS, Tait N, Minford J, Allen SL, Duggan D, Aisner J. Parnes HL, et al. J Natl Cancer Inst. 1991 Jul 17;83(14):1017-20. doi: 10.1093/jnci/83.14.1017. J Natl Cancer Inst. 1991. PMID: 2072408 Clinical Trial.

3

Chemotherapy-induced lactose intolerance in adults.

Parnes HL, Fung E, Schiffer CA. Parnes HL, et al. Cancer. 1994 Sep 1;74(5):1629-33. doi: 10.1002/1097-0142(19940901)74:5<1629::aid-cncr2820740523>3.0.co;2-l. Cancer. 1994. PMID: 8062196

4

A phase-I study of cpt-11, weekly bolus 5-fu and leucovorin in patients with metastatic cancer.

Parnes H, Tait N, Conley B, Vanecho D. Parnes H, et al. Oncol Rep. 1995 Nov;2(6):1131-4. doi: 10.3892/or.2.6.1131. Oncol Rep. 1995. PMID: 21597870

5

A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer.

Parnes HL, Abrams JS, Tchekmedyian NS, Tait N, Aisner J. Parnes HL, et al. Breast Cancer Res Treat. 1991 Aug;18(3):171-7. doi: 10.1007/BF01990033. Breast Cancer Res Treat. 1991. PMID: 1756260 Clinical Trial.

6

Current status of high-dose progestins in breast cancer.

Abrams JS, Parnes H, Aisner J. Abrams JS, et al. Among authors: parnes h. Semin Oncol. 1990 Dec;17(6 Suppl 9):68-72. Semin Oncol. 1990. PMID: 2148027 Review.

7

Studies of high-dose megestrol acetate: potential applications in cachexia.

Aisner J, Tchekmedyian NS, Tait N, Parnes H, Novak M. Aisner J, et al. Among authors: parnes h. Semin Oncol. 1988 Apr;15(2 Suppl 1):68-75. Semin Oncol. 1988. PMID: 3285486 Review.

8

A phase II study of perifosine in androgen independent prostate cancer.

Posadas EM, Gulley J, Arlen PM, Trout A, Parnes HL, Wright J, Lee MJ, Chung EJ, Trepel JB, Sparreboom A, Chen C, Jones E, Steinberg SM, Daniels A, Figg WD, Dahut WL. Posadas EM, et al. Cancer Biol Ther. 2005 Oct;4(10):1133-7. doi: 10.4161/cbt.4.10.2064. Epub 2005 Oct 1. Cancer Biol Ther. 2005. PMID: 16138006 Free article. Clinical Trial.

9

Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer.

Figg WD, Li H, Sissung T, Retter A, Wu S, Gulley JL, Arlen P, Wright JJ, Parnes H, Fedenko K, Latham L, Steinberg SM, Jones E, Chen C, Dahut W. Figg WD, et al. Among authors: parnes h. BJU Int. 2007 May;99(5):1047-55. doi: 10.1111/j.1464-410X.2007.06763.x. BJU Int. 2007. PMID: 17437439 Clinical Trial.

10

Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

Aragon-Ching JB, Ning YM, Chen CC, Latham L, Guadagnini JP, Gulley JL, Arlen PM, Wright JJ, Parnes H, Figg WD, Dahut WL. Aragon-Ching JB, et al. Among authors: parnes h. Cancer Invest. 2009 Feb;27(2):221-6. doi: 10.1080/07357900802208608. Cancer Invest. 2009. PMID: 19235596 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters